CDC Advisory Panel Could Vote on Pfizer COVID-19 Vaccine Booster

A vial of Pfizer-BioNTech COVID-19 vaccine is pictured at an Alberta Health Services vaccination clinic in Didsbury, Alta., on June 29, 2021. Jeff McIntosh/The Canadian Press

The Centers for Disease Control and Prevention (CDC) advisory panel could vote on the use of a third shot of Pfizer’s COVID-19 vaccine on Thursday.

The panel is holding a virtual, two-day meeting.